Shape-guided design of cisplatin-conjugated, mitochondrial-targeting gold nanoparticles for enhanced cytotoxic response in cancer cells

MRS Online Proceedings Library · Springer Nature · 2026-11-09 · DOI: 10.1007/s12034-026-03731-3

Аннотация

Cancer remains one of the most pressing global health challenges. The current treatments, like radiotherapy, chemotherapy and surgery, are often limited by severe side effects and recurrence. Nanoparticles, owing to their diverse shapes and sizes, have emerged as promising agents to mitigate these limitations. Simultaneously, organelle-specific targeting, particularly targeting mitochondria—the key regulators of energy production, metastasis and drug resistance—has shown potential for enhanced therapeutic outcomes. However, the size, shape and morphology of the nanoparticles play a critical role in localization in mitochondria, which is still underexplored. To address this, herein, we investigate the effect of nanoparticle shape on mitochondrial-targeting efficiency, with relevance to cancer treatment. Gold nanoparticles of three distinct morphologies: spheres, rods and stars, were engineered and surface-functionalized with cisplatin (a chemotherapeutic agent) and triphenylphosphonium (a mitochondrial-targeting moiety) group. The resulting nanoparticles were characterized using UV–visible spectroscopy and electron microscopy. Confocal microscopy, flow cytometry and cell viability assays reveal that cellular uptake and cytotoxicity are shape-dependent, following the trend gold nanostar>gold nanosphere>gold nanorod. Our findings highlight the critical influence of nanoparticle shape on mitochondrial-targeting and therapeutic efficacy, providing new insights for the development of organelle-specific nanomedicines in cancer therapy. Graphical abstract

Читать у издателя →

Похожие статьи